Skip to main content
Erschienen in: The Indian Journal of Pediatrics 5/2019

26.03.2019 | Editorial Commentary

Neuroblastoma in a Developing Country: Miles to Go

verfasst von: Jagdish Prasad Meena, Aditya Kumar Gupta

Erschienen in: Indian Journal of Pediatrics | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Excerpt

Neuroblastoma (NB) is the most common intraabdominal and extracranial solid tumor in children, accounting for approximately 8% to 10% of all childhood malignancies. As per the ‘Indian Council of Medical Research (ICMR), National Cancer Registry Program’, the relative proportion of NB (and ganglioneuroblastoma) in children (0–14 y), in seven hospital-based cancer registries across India varied from 2.4% to 7.5%. Neuroblastoma is the most common malignancy diagnosed during infancy. It can arise from anywhere along the sympathetic chain and usually presents as a mass arising in the neck, mediastinum, abdomen or pelvis. Neuroblastoma is a disease of early childhood with approximately 90% of patients presenting before the age of five years. In infants, these tumors may regress spontaneously, or they may mature into a benign ganglioneuroma. Neuroblastoma in older children is usually unresectable or is metastatic at presentation, and the overall prognosis is poor [1, 2]. …
Literatur
1.
Zurück zum Zitat Brodeur GM, Hogarty MD, Mosse YP, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams and Wilkins; 2016. p. 772–97. Brodeur GM, Hogarty MD, Mosse YP, Maris JM. Neuroblastoma. In: Pizzo PA, Poplack DG, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott Williams and Wilkins; 2016. p. 772–97.
3.
Zurück zum Zitat Kitonyi GW, Macharia WM, Mwanda OW, Pamnani R. Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital. Nairobi East Afr Med J. 2009;86:S39–46.PubMed Kitonyi GW, Macharia WM, Mwanda OW, Pamnani R. Clinico-pathologic characteristics and treatment outcomes in children with neuroblastoma at the Kenyatta National Hospital. Nairobi East Afr Med J. 2009;86:S39–46.PubMed
4.
Zurück zum Zitat Hesseling PB, Ankone K, Wessels G, Schneider JW, Plessis D, Moore L. Neuroblastoma in southern Africa: epidemiological features, prognostic factors and outcome. Ann Trop Paediatr. 1999;19:357–63.CrossRefPubMed Hesseling PB, Ankone K, Wessels G, Schneider JW, Plessis D, Moore L. Neuroblastoma in southern Africa: epidemiological features, prognostic factors and outcome. Ann Trop Paediatr. 1999;19:357–63.CrossRefPubMed
5.
Zurück zum Zitat Parise IZ, Haddad BR, Cavalli LR, et al. Neuroblastoma in southern Brazil: an 11-year study. J Pediatr Hematol Oncol. 2006;28:82–7.CrossRefPubMed Parise IZ, Haddad BR, Cavalli LR, et al. Neuroblastoma in southern Brazil: an 11-year study. J Pediatr Hematol Oncol. 2006;28:82–7.CrossRefPubMed
6.
Zurück zum Zitat Li K, Dong K, Gao J. YaoW, Xiao X, Zheng S. Neuroblastoma management in Chinese children. J Investig Surg. 2012;25:86–92.CrossRef Li K, Dong K, Gao J. YaoW, Xiao X, Zheng S. Neuroblastoma management in Chinese children. J Investig Surg. 2012;25:86–92.CrossRef
7.
Zurück zum Zitat Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24:65–86.CrossRefPubMed Park JR, Eggert A, Caron H. Neuroblastoma: biology, prognosis, and treatment. Hematol Oncol Clin North Am. 2010;24:65–86.CrossRefPubMed
8.
Zurück zum Zitat Erdelyi DJ, Elliott M, Phillips B. Urine catecholamines in paediatrics. Arch Dis Child Educ Pract Ed. 2011;96:107–11.CrossRefPubMed Erdelyi DJ, Elliott M, Phillips B. Urine catecholamines in paediatrics. Arch Dis Child Educ Pract Ed. 2011;96:107–11.CrossRefPubMed
9.
Zurück zum Zitat Matthay KK, Edeline V, Lumbroso J, et al. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003;21:2486–91.CrossRefPubMed Matthay KK, Edeline V, Lumbroso J, et al. Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma. J Clin Oncol. 2003;21:2486–91.CrossRefPubMed
10.
Zurück zum Zitat Kushner BH, Yeung HW, Larson SM, et al. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.CrossRefPubMed Kushner BH, Yeung HW, Larson SM, et al. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.CrossRefPubMed
11.
Zurück zum Zitat Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med. 2004;29:86–90.CrossRefPubMed Scanga DR, Martin WH, Delbeke D. Value of FDG PET imaging in the management of patients with thyroid, neuroendocrine, and neural crest tumors. Clin Nucl Med. 2004;29:86–90.CrossRefPubMed
12.
Zurück zum Zitat Parikh NS, Howard SC, Chantada G, et al. SIOP-PODC adapted risk stratification and treatment guidelines: recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer. 2015;62:1305–16.CrossRefPubMedPubMedCentral Parikh NS, Howard SC, Chantada G, et al. SIOP-PODC adapted risk stratification and treatment guidelines: recommendations for neuroblastoma in low- and middle-income settings. Pediatr Blood Cancer. 2015;62:1305–16.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: a 15 y experience. Indian Pediatr. 2008;45:135–9.PubMed Bansal D, Marwaha RK, Trehan A, Rao KL, Gupta V. Profile and outcome of neuroblastoma with conventional chemotherapy in children older than one year: a 15 y experience. Indian Pediatr. 2008;45:135–9.PubMed
14.
Zurück zum Zitat Agarwala S, Mandelia A, Bakhshi S, et al. Neuroblastoma: outcome over a 14 y period from a tertiary care referral centre in India. J Pediatr Surg. 2014;49:1280–5.CrossRefPubMed Agarwala S, Mandelia A, Bakhshi S, et al. Neuroblastoma: outcome over a 14 y period from a tertiary care referral centre in India. J Pediatr Surg. 2014;49:1280–5.CrossRefPubMed
15.
Zurück zum Zitat Kusumakumari P, Ajithkumar TV, Hariharan S, et al. Intensive chemotherapy in children with stage IV neuroblastoma. Indian J Pediatr. 1999;66:867–72.CrossRefPubMed Kusumakumari P, Ajithkumar TV, Hariharan S, et al. Intensive chemotherapy in children with stage IV neuroblastoma. Indian J Pediatr. 1999;66:867–72.CrossRefPubMed
16.
Zurück zum Zitat Kulkarni KP, Marwaha RK. Outcome of neuroblastoma in India. Indian J Pediatr. 2013;80:832–7.CrossRefPubMed Kulkarni KP, Marwaha RK. Outcome of neuroblastoma in India. Indian J Pediatr. 2013;80:832–7.CrossRefPubMed
Metadaten
Titel
Neuroblastoma in a Developing Country: Miles to Go
verfasst von
Jagdish Prasad Meena
Aditya Kumar Gupta
Publikationsdatum
26.03.2019
Verlag
Springer India
Erschienen in
Indian Journal of Pediatrics / Ausgabe 5/2019
Print ISSN: 0019-5456
Elektronische ISSN: 0973-7693
DOI
https://doi.org/10.1007/s12098-019-02930-7

Weitere Artikel der Ausgabe 5/2019

The Indian Journal of Pediatrics 5/2019 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.